The pharmaceutical industry has a fresh sense of direction after President Donald Trump’s tax-and-spending law included a ...

AstraZeneca's efforts are paying off as strong U.S. demand, and robust sales of newer cancer, heart and kidney disease ...

The Senate Parliamentarian reversed course on a small provision in the One Big Beautiful Bill Act that could boost cures for rare diseases.

Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part ...

Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to ...

AstraZeneca on Tuesday beat second-quarter revenue and profit expectations on robust sales of newer cancer, heart and kidney ...

If we don’t incentivize continued investments in drug research and development, we’ll lose out on new therapies that don’t ...

Drug development is a decade-long, costly process replete with failures. If we don’t incentivize investments in research and ...

Prescription drugs account for 15% of health care costs. Yet, they’re our best defense against the chronic diseases that ...

The Senate passed its version of the GOP megabill on Tuesday, and big players across the health care industry have been quick to warn of the widespread impacts of the bill’s massive Medicaid cuts.

AstraZeneca Tuesday beat second-quarter revenue and profit expectations on robust sales of newer cancer, heart and kidney ...